Pharmacology and clinical trial results of lanoteplase in acute myocardial infarction

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.11, 2000-11, pp. : 2689-2694

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction

By Moser M. Bode C.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. : 329-335

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Pharmacokinetics of Lanoteplase and Alteplase During Acute Myocardial Infarction

By Kostis J.B.

Clinical Pharmacokinetics, Vol. 41, Iss. 6, 2002-01 ,pp. : 445-452

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial Infarction: Results From GISSI-3 Trial

By Franzosi M.G. Maggioni A.P. Santoro E. Tognoni G. Cavalieri E.

PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. : 337-346

Adis International

Access to resources Recommend Favorite

Tenecteplase: A Review of its Pharmacology and Therapeutic Efficacy in Patients with Acute Myocardial Infarction

By Dunn C.J. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 1, 2001-01 ,pp. : 51-66

Adis International

Access to resources Recommend Favorite

VALIANT (VALsartan In Acute myocardial iNfarcTion) trial

By Maggioni Aldo Pietro Fabbri Gianna

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 507-512

Informa Healthcare

Access to resources Recommend Favorite